Cooley secured a summary judgment with prejudice for Aurinia Pharmaceuticals (Aurinia), a Canada-based company focused on developing therapies to treat autoimmune diseases, in a securities class action challenging numerous public statements made over a period of nine months. The Cooley team was led by securities litigation and enforcement partners Koji Fukumura and Ryan Blair, with support from associates Heather Speers, Matt Martinez and Jessica Taylor. The case is Michael J. Ortmann v. Aurinia Pharmaceuticals, Inc. et al. (Case No.: 22-1335-BAH).
